ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 148 filers reported holding ACCELERON PHARMA INC in Q4 2016. The put-call ratio across all filers is 3.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $19,701,000 | -28.1% | 771,977 | +1.9% | 0.00% | -25.0% |
| Q3 2016 | $27,419,000 | +10.4% | 757,640 | +3.7% | 0.00% | 0.0% |
| Q2 2016 | $24,833,000 | +45.5% | 730,806 | +13.0% | 0.00% | +33.3% |
| Q1 2016 | $17,065,000 | -37.0% | 646,645 | +16.4% | 0.00% | -25.0% |
| Q4 2015 | $27,095,000 | +135.2% | 555,680 | +20.1% | 0.00% | +100.0% |
| Q3 2015 | $11,521,000 | +16.5% | 462,710 | +48.1% | 0.00% | 0.0% |
| Q2 2015 | $9,888,000 | -11.1% | 312,530 | +6.9% | 0.00% | 0.0% |
| Q1 2015 | $11,124,000 | +38.0% | 292,281 | +41.3% | 0.00% | +100.0% |
| Q4 2014 | $8,062,000 | +56.5% | 206,920 | +21.4% | 0.00% | 0.0% |
| Q3 2014 | $5,153,000 | -16.7% | 170,396 | -6.4% | 0.00% | 0.0% |
| Q2 2014 | $6,187,000 | +121.4% | 182,121 | +124.8% | 0.00% | – |
| Q1 2014 | $2,795,000 | -56.0% | 81,000 | -49.5% | 0.00% | -100.0% |
| Q4 2013 | $6,349,000 | – | 160,336 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 1,103,937 | $53,563,000 | 5.39% |
| GREAT POINT PARTNERS LLC | 758,000 | $36,778,000 | 5.10% |
| Foresite Capital Management II, LLC | 244,756 | $11,876,000 | 4.18% |
| GREAT POINT PARTNERS LLC | 552,300 | $26,798,000 | 3.71% |
| Foresite Capital Management III, LLC | 278,753 | $13,525,000 | 2.91% |
| QVT Financial LP | 190,977 | $9,266,000 | 2.66% |
| Perceptive Advisors | 1,528,205 | $74,149,000 | 1.94% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,126,800 | $54,672,000 | 1.92% |
| SECTORAL ASSET MANAGEMENT INC | 306,626 | $14,877,000 | 1.66% |
| Parametrica Management Ltd | 5,645 | $274,000 | 1.30% |